NEW WESTMINSTER, BRITISH COLUMBIA--(CCNMatthews - April 27, 2007) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) (the “Company”) announces that insiders of the Company have completed the sale of 3,205,825 common shares of ALDA at prices ranging from $0.11 to $0.17 per share through the TSX Venture Exchange. The proceeds obtained through the sale of these shares were used by these insiders to exercise 900,000 options and will also be used to subscribe for Units of the private placement announced on April 4, 2007.